- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines (24h)
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Labopharm Inc. | Company Snapshot
-
-
-
-
Vol:
-
Last Trade:
LABOPHARM INC.
LABOPHARM INC. is a pharmaceutical company engaged in the development of drugs with contolled-release delivery.
|
|
Symbol: |
DDS |
Exchange(s): |
Toronto Stock Exchange |
Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
5-Star Rating: |
![](https://bac-lac.wayback.archive-it.org/web/20100212144120im_/http://gold.globeinvestor.com/images/ora/stocks/3stars.gif) |
ANNUAL FINANCIALS
|
|
Dec 31, 2008 12 Months C$
|
Dec 31, 2007 12 Months C$
|
Dec 31, 2006 12 Months C$
|
3Yr. Growth % Change
|
Total Revenue ($000)
|
23,888
|
22,476
|
20,261
|
79.21
|
Earnings before Interest & Tax ($000)
|
-37,453
|
-32,143
|
-19,283
|
N/A
|
Profit/Loss ($000)
|
-40,527
|
-36,575
|
-23,865
|
N/A
|
Earnings per Share
|
-0.71
|
-0.64
|
-0.46
|
N/A
|
Total Assets ($000)
|
69,851
|
99,539
|
128,634
|
8.62
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
Return on Com. Equity
|
-127.55
|
-55.63
|
-60.45
|
|
Employees
|
168
|
158
|
133
|
|
|
|
Trailing 12 Month Results
|
|
12 Months ended Sep 30, 2009, C$
|
12 Months ended Sep 30, 2008, C$
|
%Change
|
Total Revenue ($000)
|
26,661
|
21,786
|
22.38
|
Profit/Loss ($000)
|
-34,470
|
-36,049
|
4.38
|
Earnings per Share
|
-0.61
|
-0.64
|
4.69
|
Dividends Per Share
|
0.00
|
0.00
|
Number of Shares
|
57,411,663
|
56,826,063
|
|
|
|
COMPANY INFORMATION
|
Report on Business Magazine Top 1000 Ranking
|
Profit: 0871 |
Revenue: 0734 |
Assets: 0822 |
|
|
Key Personnel |
CEO: James Howard-Tripp, President & C.E.O. |
CFO: Mark D'Souza, Senior V.P. & Chief Financial |
|
Contact Information |
Address: |
480 Armand-Frappier Blvd., Laval, QC, H7V 4B4 |
Phone: |
450-686-1017 |
Fax: |
450-686-9141 |
Web Address: |
www.labopharm.com |
E-Mail : |
info@labopharm.com |
Investor Relations: |
Mark D'Souza, 450-686-0207 |
|
Company Type: |
Public |
Company Status: |
Active |
Auditors: |
Ernst & Young Llp |
Transfer Agent: |
Computershare Trust Co. Of Can |
Incorporation:
| Quebec, Oct 26, 1990 |
|
Securities:
|
DDSS-Q DDS-T
|
|
|
|
|
|
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|